A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. [electronic resource]
Producer: 20060307Description: 771-8 p. digitalISSN:- 0394-6320
- Adolescent
- Adult
- Caffeine -- therapeutic use
- Central Nervous System Stimulants -- therapeutic use
- Disability Evaluation
- Female
- Histamine H1 Antagonists -- adverse effects
- Humans
- Hydroxyzine -- adverse effects
- Male
- Multiple Sclerosis -- drug therapy
- Multiple Sclerosis, Chronic Progressive -- drug therapy
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Pilot Projects
- Upper Extremity -- physiology
- Walking -- physiology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.